, Volume 22, Issue 3, pp 175–179 | Cite as

Safety of continuous subcutaneous insulin infusion: Metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion

  • J. C. Pickup
  • G. C. Viberti
  • R. W. Bilous
  • H. Keen
  • K. G. M. M. Alberti
  • P. D. Home
  • C. Binder


To assess the rate of metabolic deterioration and potential risks of failure of continuous subcutaneous insulin infusion during basal insulin delivery, we deliberately stopped infusion in nine insulin dependent diabetics. Plasma glucose, blood 3-hydroxybutyrate and plasma free insulin were measured for 9 h whilst the patients remained supine and fasting. Mean plasma glucose remained unchanged at normal fasting levels for the first hour, then rose to plateau at about 10 mmol/l until the end of the experiment. The final plateau level of glucose varied from patient to patient; two C-peptide secreting diabetics plateaued at low glucose levels. In contrast, blood 3-hydroxybutyrate rose progressively, without plateauing. Plasma free insulin concentrations fell during the withdrawal period and there was a highly significant negative correlation between free insulin and 3-hydroxybutyrate. No patient was more than mildly unwell after 9 h of insulin deprivation. We conclude that under these experimental conditions there is glycaemic autoregulation and that ketones may sometimes be a more appropriate monitor of insulin deficiency or loss of diabetic control than is glucose. Accidental failure of continuous subcutaneous insulin infusion and interruption of basal delivery in resting and fasting diabetics will probably not cause dangerous metabolic or clinical deterioration.

Key words

Continuous subcutaneous insulin infusion insulin withdrawal ketoacidosis glucose regulation 


  1. 1.
    Pickup JC, Keen H, Parsons JA, Alberti KGMM (1978) Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J 1:204–207Google Scholar
  2. 2.
    Pickup JC, Keen H, Parsons JA, Alberti KGMM, Rowe AS (1979) Continuous subcutaneous insulin infusion: improved blood glucose and intermediary metabolite control in diabetics. Lancet 1: 1255–1258Google Scholar
  3. 3.
    Pickup JC, White MC, Keen H, Kohner EM, Parsons JA, Alberti KGMM (1979) Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet 2: 870–873Google Scholar
  4. 4.
    Pickup JC, Keen H, Viberti GC, White MC, Kohner EM, Parsons JA, Alberti KGMM (1980) Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care 3: 290–300Google Scholar
  5. 5.
    Tamborlane WV, Sherwin RS, Genel M, Felig P (1979) Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 300: 573–578Google Scholar
  6. 6.
    Tamborlane WV, Sherwin RS, Genel M, Felig P (1980) Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. Am J Med 68: 190–196Google Scholar
  7. 7.
    Champion MC, Shepherd GAA, Rodger NW, Dupré J (1980) Continuous subcutaneous insulin infusion in the management of diabetes mellitus. Diabetes 29:206–212Google Scholar
  8. 8.
    Pickup JC, Viberti GC, Bilous RW, Dalton N, Binder C, Bloom SR, Keen H (1980) Metabolic and hormonal decompensation after deliberate withdrawal of prolonged subcutaneous insulin infusion. Diabetologia 19: 563 (Abstract)Google Scholar
  9. 9.
    Keen H, Pickup JC, Viberti GC, Bilous R, Williams G (1981) Aspects of continuous subcutaneous insulin infusion (CSII) in diabetes. Diabetes Care 4: 54–57Google Scholar
  10. 10.
    Lloyd B, Burrin J, Smythe P, Alberti KGMM (1978) Enzymatic fluorimetric continuous flow assays for blood glucose, lactate, pyruvate, alanine, glycerol and 3-hydroxybutyrate. Clin Chem 24: 1724–1729Google Scholar
  11. 11.
    Faber OK, Binder C (1977) C-peptide response to glucagon. Atest for the residual β-cell function in diabetes mellitus. Diabetes 26: 605–610Google Scholar
  12. 12.
    Nakagawa S, Nakayama H, Sossaki T, Yoshimo K, Yu Y, Shimozaki K, Aoki S, Mashimo K (1973) Simple method for the determination of serum free insulin levels in insulin treated patients. Diabetes 22: 590–600Google Scholar
  13. 13.
    Cahill GF, Hernera MG, Morgan AP, Soeldner JS, Steinke J, Levy PL, Reichard G A, Kipnis DM (1966) Hormone-fuel interrelationships during fasting. J Clin Invest 45: 1751–1769Google Scholar
  14. 14.
    Barnes AJ, Bloom SR, Alberti KGMM, Smythe P, Alford FP, Chisholm DJ (1977) Ketoacidosis in pancreatectomised man. N Engl J Med 296: 1250–1253Google Scholar
  15. 15.
    Madsbad S, Alberti KGMM, Binder C, Burrin JM, Faber OK, Krarup T, Regeur L (1979) Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. Br Med J 2: 1257–1259Google Scholar
  16. 16.
    Miles JM, Rizza RA, Haymond MW, Gerich JE (1980) Effects of acute insulin deficiency on glucose and ketone body turnover in man. Diabetes 28:926–930Google Scholar
  17. 17.
    Sacca L, Cryer PE, Sherwin RS (1979) Blood glucose regulates the effects of insulin and counterregulatory hormones on glucose production in vivo. Diabetes 28: 533–536Google Scholar
  18. 18.
    Sacca L, Sherwin RS, Hendler R, Felig P (1979) Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counter-regulatory hormones in normal and diabetic humans. J Clin Invest 63:849–857Google Scholar
  19. 19.
    Liljenquist JE, Mueller GL, Cherrington AD, Perry JM, Rabinowitz D (1979) Hyperglycaemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man. J Clin Endocrinol Metab 48: 171–175Google Scholar
  20. 20.
    Keller U, Sonnenberg GE, Berger W (1981) Ketone body turnover rates in insulin-dependent diabetics following short-term withdrawal of a continuous S.C. infusion of insulin. Eur J Clin Invest (in press)Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • J. C. Pickup
    • 1
  • G. C. Viberti
    • 1
  • R. W. Bilous
    • 1
  • H. Keen
    • 1
  • K. G. M. M. Alberti
    • 2
  • P. D. Home
    • 2
  • C. Binder
    • 3
  1. 1.Unit for Metabolic MedicineGuy's Hospital Medical SchoolLondon
  2. 2.Department of Clinical BiochemistryRoyal Victoria InfirmaryNewcastle-upon-TyneUK
  3. 3.Steno Memorial HospitalGentofteDenmark

Personalised recommendations